• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

CNS National Sales Meetings





















So much for One for All Abbvie motto. Ridiculous to have a live National meeting in the highest point of the pandemic. There are reps with pre existing conditions. Not to mention flight cancellations are ridiculous right now. Better to play it safe
 
















Does anyone else’s DM make them look at PAs with offices and try to infer the adjunct MDD indication without actually saying we’re indicated for adjunct MDD? Asking for a friend…..!!